The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Cardiovascular Surgery Devices And Equipment Market During The Forecast Period 2026–2030?
The cardiovascular surgery devices and equipment market has experienced marginal expansion in recent years. It is forecast to grow from $1.8 billion in 2025 to $1.82 billion in 2026, with a compound annual growth rate (CAGR) of 0.7%. The market’s past growth was primarily due to a higher prevalence of cardiovascular disorders, an increase in cardiac surgery procedures, the introduction of advanced surgical equipment, the development of specialized cardiac hospitals, and the growing embrace of bypass and ablation systems.
The cardiovascular surgery devices and equipment market is projected to experience consistent expansion over the upcoming years. By 2030, its valuation is anticipated to reach $2.06 billion, demonstrating a compound annual growth rate (CAGR) of 3.1%. This expansion during the forecast period is propelled by factors such as a heightened call for less invasive cardiac procedures, increased capital directed towards advanced surgical systems, the spread of hybrid cardiac operating facilities, the expanding application of AI in surgical planning, and ongoing advancements in cardiovascular surgical instruments. Key developments anticipated in this period encompass the greater uptake of minimally invasive cardiac surgery tools, the increasing application of sophisticated cardiac ablation techniques, enhanced accuracy in cardiopulmonary bypass systems, the broadening of beating heart surgery methods, and a sharpened emphasis on optimizing surgical results.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2389&type=smp
Which Economic Or Industry Drivers Are Impacting The Cardiovascular Surgery Devices And Equipment Market?
The expanding geriatric population is projected to propel the growth of the cardiovascular surgical devices market moving forward. This demographic refers to individuals aged 65 years and older who are considered older adults within a population. They are characterized by increased healthcare needs stemming from age-related physiological changes and a greater prevalence of chronic conditions. Cardiovascular surgical devices assist the geriatric population by enabling safer, minimally invasive procedures that address age-related heart conditions and improve overall survival and quality of life. For instance, in October 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, the number of people 80 years of age or older is predicted to treble to 426 million between 2020 and 2050. Consequently, the rising geriatric population is driving the growth of the cardiovascular surgical devices market.
What Market Segments Are Evaluated Within The Cardiovascular Surgery Devices And Equipment Market?
The cardiovascular surgery devices and equipment market covered in this report is segmented –
1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables
2) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications
3) By End User: Ambulatory Surgical Centers, Hospitals, Cardiac Specialty Centers, Research Laboratories
Subsegments:
1) By Beating Heart Surgery Systems: Stabilization Systems, Tissue Stabilizers, Coronary Artery Bypass Surgery Systems, Other Beating Heart Surgery Devices
2) By Cardiopulmonary Bypass Equipment: Heart-Lung Machines, Oxygenators, Cannulas, Tubing Packs, Cardioplegia Delivery Systems, Other Cardiopulmonary Bypass Equipment
3) By Cardiac Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices, Laser Ablation Devices, Microwave Ablation Devices, Other Cardiac Ablation Devices
4) By Perfusion Disposables: Blood Oxygenators, Perfusion Cannulas, Tubing Sets, Filters, Blood Reservoirs, Other Perfusion Disposables
What Industry Trends Are Redefining The Cardiovascular Surgery Devices And Equipment Market?
Leading corporations are allocating capital to firms within the cardiovascular surgery devices and Equipment market, especially those dedicated to creating novel solutions like CardioVisio for Atrial Fibrillation (AFib), with the goals of improving early detection, bettering patient results, and simplifying treatment processes. CardioVisio for Atrial Fibrillation (AFib) serves as a sophisticated diagnostic and monitoring tool specifically developed to identify and oversee AFib, which is a prevalent form of irregular heart rhythm. An example of this is the launch of CardioVisio for Atrial Fibrillation (AFib) by GE HealthCare, a medical technology firm based in the US, in August 2023. This digital clinical decision support tool is intended to elevate precision care for individuals with AFib. Unveiled at the ESC Congress 2023, this groundbreaking solution incorporates long-term patient data from diverse origins, offering medical professionals an exhaustive perspective on cardiac well-being. Through its provision of evidence-backed recommendations consistent with AFib guidelines, CardioVisio optimizes clinical procedures and boosts compliance with optimal medical standards.
Who Are The Top Market Participants Influencing The Cardiovascular Surgery Devices And Equipment Market?
Major companies operating in the cardiovascular surgery devices and equipment market are Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., TransMedics, Terumo Cardiovascular Systems Corporation, Edwards Lifesciences Corporation, Medtronic plc, Cyberheart Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.p.A., Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., LivaNova PLC, CryoLife Inc., Artivion Inc.
Read the full cardiovascular surgery devices and equipment market report here:
What Are The Top-Performing Regions Within The Cardiovascular Surgery Devices And Equipment Market?
North America was the largest region in the global cardiovascular surgery devices and equipment market in 2025. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cardiovascular Surgery Devices And Equipment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2389&type=smp
Browse Through More Reports Similar to the Global Cardiovascular Surgery Devices And Equipment Market 2026, By The Business Research Company
Cosmetic Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/cosmetic-implants-global-market-report
Smart Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-implants-global-market-report
Dental Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/dental-implants-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model